铁死亡与激素性股骨头坏死的研究进展及相关铁死亡基因在骨代谢或氧化应激方面的讨论
Advances in Ferroptosis and Glucocorticoid-Induced Osteonecrosis of Femoral Head and Discussion of Related Ferroptosis Genes in Bone Metabolism or Oxidative Stress
DOI: 10.12677/acm.2025.151230, PDF,   
作者: 王绍庚*：深圳大学第二附属医院创伤骨科与矫形外科，广东 深圳；黄富超：广东医科大学深圳宝安临床医学院，广东 深圳；汤家骏：暨南大学附属第二临床医学院，广东 深圳
关键词: 激素性股骨头坏死；铁死亡；氧化应激；Steroid-Induced Osteonecrosis of the Femoral Head； Ferroptosis； Oxidative Stress
摘要: 背景：越来越多研究表明铁死亡可能参与激素性股骨头坏死的发生与发展。目的：探讨铁死亡与激素性股骨头坏死的关系，为其诊治提供新的思路。方法：以“铁死亡，股骨头坏死”为中文检索词，以“ferroptosis, necrosis of the femoral head”为英文检索词，检索PubMed、Science Citation Index Expanded、ScienceDirect、Scopus、万方、维普、中国知网数据库，筛选激素性股骨头坏死与铁死亡研究相关文章进行综述分析。结果与结论：① 铁死亡在激素性股骨头坏死发病中起重要作用。② 激素性股骨头坏死中铁死亡的发生受到多种机制通路调控。通过生物信息学方法筛选出的许多激素相关性股骨头坏死铁死亡相关基因仍需进一步的体内体外实验验证。③ 目前关于激素性股骨头坏死铁死亡相关机制尚不明确，亟需深入探明两者的作用机制，有望为激素性股骨头坏死提供新的治疗思路。
Abstract: Background: Ferroptosis may be involved in the development and progression of steroid-induced osteonecrosis of the femoral head. Objective: To explore the relationship between ferroptosis and steroid-induced osteonecrosis of femoral head, and to provide new ideas for steroid-induced osteonecrosis of femoral head diagnosis and treatment. Methods: Using “ferroptosis, osteonecrosis of the femoral head” as the Chinese search term and “ferroptosis, necrosis of the femoral head” as the English search term, we searched the PubMed, Science Citation Index Expanded, ScienceDirect, Scopus, Wanfang and VIP databases, and screened the articles related to the study of ferroptosis and steroid-induced osteonecrosis of femoral head from the establishment of the databases to 2024, and conducted a review analysis. Results and Conclusions: ① Ferroptosis plays an important role in the pathogenesis of steroid-induced osteonecrosis of the femoral head. ② Ferroptosis in steroid-induced osteonecrosis of femoral head is regulated by various mechanisms. Many of the genes associated with ferroptosis in steroid-induced osteonecrosis of the femoral head screened by bioinformatics methods still need to be validated by further in vivo and in vitro experiments. ③ The mechanism of ferroptosis in steroid-induced osteonecrosis of the femoral head is still unclear. Further investigation on the mechanism of action of both is expected to provide new therapeutic ideas for steroid-induced osteonecrosis of the femoral head.
文章引用：王绍庚, 黄富超, 汤家骏. 铁死亡与激素性股骨头坏死的研究进展及相关铁死亡基因在骨代谢或氧化应激方面的讨论[J]. 临床医学进展, 2025, 15(1): 1717-1730. https://doi.org/10.12677/acm.2025.151230

参考文献

[1] Barney, J., Piuzzi, N.S. and Akhondi, H. (2023) Femoral Head Avascular Necrosis. StatPearls.
[2] Tan, B., Li, W., Zeng, P., Guo, H., Huang, Z., Fu, F., et al. (2020) Epidemiological Study Based on China Osteonecrosis of the Femoral Head Database. Orthopaedic Surgery, 13, 153-160. [Google Scholar] [CrossRef] [PubMed]
[3] Zhang, Q., Li, Z., Gao, F. and Sun, W. (2018) Pericollapse Stage of Osteonecrosis of the Femoral Head: A Last Chance for Joint Preservation. Chinese Medical Journal, 131, 2589-2598. [Google Scholar] [CrossRef] [PubMed]
[4] Bai, R., Feng, W., Liu, W.L., Zhao, Z.H.Q., Zhao, A.Q., Wang, Y., et al. (2016) Roles of Osteocyte Apoptosis in Steroid-Induced Avascular Necrosis of the Femoral Head. Genetics and Molecular Research, 15, gmr.15017529. [Google Scholar] [CrossRef] [PubMed]
[5] Chang, C., Greenspan, A. and Gershwin, M.E. (2020) The Pathogenesis, Diagnosis and Clinical Manifestations of Steroid-Induced Osteonecrosis. Journal of Autoimmunity, 110, Article ID: 102460. [Google Scholar] [CrossRef] [PubMed]
[6] Zhu, S., Zhuang, J., Wu, Q., Liu, Z., Liao, C., Luo, S., et al. (2018) Advanced Oxidation Protein Products Induce Pre‐osteoblast Apoptosis through a Nicotinamide Adenine Dinucleotide Phosphate Oxidase‐Dependent, Mitogen‐Activated Protein Kinases‐Mediated Intrinsic Apoptosis Pathway. Aging Cell, 17, e12764. [Google Scholar] [CrossRef] [PubMed]
[7] 章喻, 王利波, 戴薇薇. 糖皮质激素与铁死亡[J]. 生理科学进展, 2022, 53(1): 76-81.
[8] Zheng, H., Jiang, J., Xu, S., Liu, W., Xie, Q., Cai, X., et al. (2021) Nanoparticle-Induced Ferroptosis: Detection Methods, Mechanisms and Applications. Nanoscale, 13, 2266-2285. [Google Scholar] [CrossRef] [PubMed]
[9] Hassannia, B., Van Coillie, S. and Vanden Berghe, T. (2021) Ferroptosis: Biological Rust of Lipid Membranes. Antioxidants & Redox Signaling, 35, 487-509. [Google Scholar] [CrossRef] [PubMed]
[10] Li, J., Cao, F., Yin, H., Huang, Z., Lin, Z., Mao, N., et al. (2020) Ferroptosis: Past, Present and Future. Cell Death & Disease, 11, Article No. 88. [Google Scholar] [CrossRef] [PubMed]
[11] Battaglia, A.M., Chirillo, R., Aversa, I., Sacco, A., Costanzo, F. and Biamonte, F. (2020) Ferroptosis and Cancer: Mitochondria Meet the “Iron Maiden” Cell Death. Cells, 9, Article 1505. [Google Scholar] [CrossRef] [PubMed]
[12] Bannai, S. and Kitamura, E. (1980) Transport Interaction of L-Cystine and L-Glutamate in Human Diploid Fibroblasts in Culture. Journal of Biological Chemistry, 255, 2372-2376. [Google Scholar] [CrossRef] [PubMed]
[13] Dolma, S., Lessnick, S.L., Hahn, W.C. and Stockwell, B.R. (2003) Identification of Genotype-Selective Antitumor Agents Using Synthetic Lethal Chemical Screening in Engineered Human Tumor Cells. Cancer Cell, 3, 285-296. [Google Scholar] [CrossRef] [PubMed]
[14] Yang, W.S. and Stockwell, B.R. (2008) Synthetic Lethal Screening Identifies Compounds Activating Iron-Dependent, Nonapoptotic Cell Death in Oncogenic-Ras-Harboring Cancer Cells. Chemistry & Biology, 15, 234-245. [Google Scholar] [CrossRef] [PubMed]
[15] Dixon, S.J., Lemberg, K.M., Lamprecht, M.R., Skouta, R., Zaitsev, E.M., Gleason, C.E., et al. (2012) Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death. Cell, 149, 1060-1072. [Google Scholar] [CrossRef] [PubMed]
[16] Chen, H., Han, Z., Wang, Y., Su, J., Lin, Y., Cheng, X., et al. (2023) Targeting Ferroptosis in Bone-Related Diseases: Facts and Perspectives. Journal of Inflammation Research, 16, 4661-4677. [Google Scholar] [CrossRef] [PubMed]
[17] Jing, X., Du, T., Yang, X., Zhang, W., Wang, G., Liu, X., et al. (2020) Desferoxamine Protects against Glucocorticoid‐Induced Osteonecrosis of the Femoral Head via Activating HIF‐1α Expression. Journal of Cellular Physiology, 235, 9864-9875. [Google Scholar] [CrossRef] [PubMed]
[18] 陶红成, 曾平, 刘金富, 等. 三七总皂苷调控破骨细胞外泌体中差异miRNA表达抑制成骨细胞铁死亡[J]. 中国组织工程研究, 2025, 29(19): 4011-4021.
http://kns.cnki.net/kcms/detail/21.1581.R.20240508.1000.014.html
[19] Sun, F., Zhou, J.L., Liu, Z.L., Jiang, Z.W. and Peng, H. (2022) Dexamethasone Induces Ferroptosis via P53/SLC7A11/GPX4 Pathway in Glucocorticoid-Induced Osteonecrosis of the Femoral Head. Biochemical and Biophysical Research Communications, 602, 149-155. [Google Scholar] [CrossRef] [PubMed]
[20] Zhang, Y., Hu, K., Shang, Z., Yang, X. and Cao, L. (2024) Ferroptosis: Regulatory Mechanisms and Potential Targets for Bone Metabolism: A Review. Medicine (Baltimore), 103, e39158. [Google Scholar] [CrossRef] 
[21] Yang, W.S., SriRamaratnam, R., Welsch, M.E., Shimada, K., Skouta, R., Viswanathan, V.S., et al. (2014) Regulation of Ferroptotic Cancer Cell Death by GPX4. Cell, 156, 317-331. [Google Scholar] [CrossRef] [PubMed]
[22] Jia, M., Qin, D., Zhao, C., Chai, L., Yu, Z., Wang, W., et al. (2020) Redox Homeostasis Maintained by GPX4 Facilitates STING Activation. Nature Immunology, 21, 727-735. [Google Scholar] [CrossRef] [PubMed]
[23] 章家皓, 刘予豪, 周驰, 等. 氧化应激促进成骨细胞铁死亡介导激素性股骨头坏死的病理过程[J]. 中国组织工程研究, 2024, 28(20): 3202-3208.
[24] 郑嘉乾. 股骨头GPX4含量及人参皂苷Rg3调控GPX4对MSCs成骨分化的影响[D]: [硕士学位论文]. 广州: 广州中医药大学, 2021.
[25] 张绵钰, 韩杰, 曾浩, 等. 中药调控成骨细胞铁死亡治疗激素性股骨头坏死[J]. 中国组织工程研究, 2025, 29(1): 185-192.
[26] Khan, R.I., Nirzhor, S.S.R. and Akter, R. (2018) A Review of the Recent Advances Made with SIRT6 and Its Implications on Aging Related Processes, Major Human Diseases, and Possible Therapeutic Targets. Biomolecules, 8, Article 44. [Google Scholar] [CrossRef] [PubMed]
[27] Fang, L., Zhang, G., Wu, Y., Li, Z., Gao, S. and Zhou, L. (2022) SIRT6 Prevents Glucocorticoid-Induced Osteonecrosis of the Femoral Head in Rats. Oxidative Medicine and Cellular Longevity, 2022, Article ID: 6360133. [Google Scholar] [CrossRef] [PubMed]
[28] Li, W., Zhang, W., Sun, H., Li, W., Qin, Y., Wang, L., et al. (2023) Harmine Ameliorates Steroid-Induced Osteonecrosis of the Femoral Head by Modulating Metabolism and Ferroptosis via HIF1-α. Fundamental Research. [Google Scholar] [CrossRef] 
[29] Cipolla-Neto, J. and Amaral, F.G.D. (2018) Melatonin as a Hormone: New Physiological and Clinical Insights. Endocrine Reviews, 39, 990-1028. [Google Scholar] [CrossRef] [PubMed]
[30] Li, W., Li, W., Zhang, W., Wang, H., Yu, L., Yang, P., et al. (2023) Exogenous Melatonin Ameliorates Steroid-Induced Osteonecrosis of the Femoral Head by Modulating Ferroptosis through GDF15-Mediated Signaling. Stem Cell Research & Therapy, 14, Article No. 171. [Google Scholar] [CrossRef] [PubMed]
[31] 余鹏, 孟东方, 李慧英, 等. CA9作为激素性股骨头坏死中软骨铁死亡特征基因的生物信息学鉴定[J]. 中国组织工程研究, 2024, 28(27): 4293-4299.
[32] 邵学坤, 王成, 王仪, 等. 鹿角多肽调控SLC7A11/GPX4轴抑制地塞米松诱导的成骨细胞铁死亡[J]. 中国组织工程研究, 2025, 29(14): 2875-2881.
[33] 张聿轲. 激素性股骨头坏死中铁死亡靶点基因模型的筛选与验证研究[D]: [硕士学位论文]. 呼和浩特: 内蒙古医科大学, 2023.
[34] 梁学振, 骆帝, 李嘉程, 等. 激素性股骨头坏死中的PTGS2和STAT3: 潜在铁死亡相关诊断生物标志物[J]. 中国组织工程研究, 2023, 27(36): 5898-5904.
[35] Huang, X., Meng, H., Shou, Z., Zhou, H., Chen, L., Yu, J., et al. (2024) Machine Learning‐Mediated Identification of Ferroptosis‐Related Genes in Osteonecrosis of the Femoral Head. FEBS Open Bio, 14, 455-465. [Google Scholar] [CrossRef] [PubMed]
[36] Lu, H., Fan, Y., Yan, Q., Chen, Z., Wei, Z., Liu, Y., et al. (2023) Identification and Validation of Ferroptosis-Related Biomarkers in Steroid-Induced Osteonecrosis of the Femoral Head. International Immunopharmacology, 124, Article ID: 110906. [Google Scholar] [CrossRef] [PubMed]
[37] Liu, J., Han, X., Qu, L. and Du, B. (2023) Identification of Key Ferroptosis-Related Biomarkers in Steroid-Induced Osteonecrosis of the Femoral Head Based on Machine Learning. Journal of Orthopaedic Surgery and Research, 18, Article No. 327. [Google Scholar] [CrossRef] [PubMed]
[38] Chen, N., Meng, Y., Zhan, H. and Li, G. (2023) Identification and Validation of Potential Ferroptosis-Related Genes in Glucocorticoid-Induced Osteonecrosis of the Femoral Head. Medicina, 59, Article 297. [Google Scholar] [CrossRef] [PubMed]
[39] Luo, Y., Gao, X., Zou, L., Lei, M., Feng, J. and Hu, Z. (2021) Bavachin Induces Ferroptosis through the STAT3/P53/SLC7A11 Axis in Osteosarcoma Cells. Oxidative Medicine and Cellular Longevity, 2021, Article ID: 1783485. [Google Scholar] [CrossRef] [PubMed]
[40] Wang, C., Liu, H., Xu, S., Deng, Y., Xu, B., Yang, T., et al. (2023) Ferroptosis and Neurodegenerative Diseases: Insights into the Regulatory Roles of SLC7A11. Cellular and Molecular Neurobiology, 43, 2627-2642. [Google Scholar] [CrossRef] [PubMed]
[41] Deng, X., Lin, B., Wang, F., Xu, P. and Wang, N. (2024) Mangiferin Attenuates Osteoporosis by Inhibiting Osteoblastic Ferroptosis through Keap1/Nrf2/SLC7A11/GPX4 Pathway. Phytomedicine, 124, Article ID: 155282. [Google Scholar] [CrossRef] [PubMed]
[42] Schipani, E., Ryan, H.E., Didrickson, S., Kobayashi, T., Knight, M. and Johnson, R.S. (2001) Hypoxia in Cartilage: HIF-1α Is Essential for Chondrocyte Growth Arrest and Survival. Genes & Development, 15, 2865-2876. [Google Scholar] [CrossRef] [PubMed]
[43] Bentovim, L., Amarilio, R. and Zelzer, E. (2012) HIF1α Is a Central Regulator of Collagen Hydroxylation and Secretion under Hypoxia during Bone Development. Development, 139, 4473-4483. [Google Scholar] [CrossRef] [PubMed]
[44] Zhang, W., Xia, C., Qu, Y., Li, J., Liu, J., Ou, S., et al. (2024) MicroRNA-18a Regulates the Pyroptosis, Apoptosis, and Necroptosis (PANoptosis) of Osteoblasts Induced by Tumor Necrosis Factor-α via Hypoxia-Inducible Factor-1α. International Immunopharmacology, 128, Article ID: 111453. [Google Scholar] [CrossRef] [PubMed]
[45] Yang, S., Kim, J., Ryu, J., Oh, H., Chun, C., Kim, B.J., et al. (2010) Hypoxia-Inducible Factor-2α Is a Catabolic Regulator of Osteoarthritic Cartilage Destruction. Nature Medicine, 16, 687-693. [Google Scholar] [CrossRef] [PubMed]
[46] Hong, S.W. and Kang, J. (2022) Growth Differentiation Factor-15 as a Modulator of Bone and Muscle Metabolism. Frontiers in Endocrinology, 13, Article 948176. [Google Scholar] [CrossRef] [PubMed]
[47] Chen, J., Cui, Z., Wang, Y., Lyu, L., Feng, C., Feng, D., et al. (2022) Cyclic Polypeptide D7 Protects Bone Marrow Mesenchymal Cells and Promotes Chondrogenesis during Osteonecrosis of the Femoral Head via Growth Differentiation Factor 15-Mediated Redox Signaling. Oxidative Medicine and Cellular Longevity, 2022, Article ID: 3182368. [Google Scholar] [CrossRef] [PubMed]
[48] Wykoff, C.C., Beasley, N.J., Watson, P.H., et al. (2000) Hypoxia-Inducible Expression of Tumor-Associated Carbonic Anhydrases. Cancer Research, 60, 7075-7083.
[49] Marchini Armentano, G., Pieretti, J.C., Falconi, C.A., Barozzi Seabra, A. and Carneiro-Ramos, M.S. (2024) Nitric Oxide Plays a Dual Role in Cardiorenal Syndrome in Vitro Model. Cellular Physiology and Biochemistry, 58, 33-48. [Google Scholar] [CrossRef] [PubMed]
[50] Yan, Y., Lu, A., Dou, Y., Zhang, Z., Wang, X., Zhai, L., et al. (2023) Nanomedicines Reprogram Synovial Macrophages by Scavenging Nitric Oxide and Silencing CA9 in Progressive Osteoarthritis. Advanced Science, 10, e2207490. [Google Scholar] [CrossRef] [PubMed]
[51] Jiang, N., Liu, J., Guan, C., Ma, C., An, J. and Tang, X. (2022) Thioredoxin-Interacting Protein: A New Therapeutic Target in Bone Metabolism Disorders? Frontiers in Immunology, 13, Article 955128. [Google Scholar] [CrossRef] [PubMed]
[52] Zhou, W., Zhu, C. and Zhou, F. (2024) TXNIP Mediated by EZH2 Regulated Osteogenic Differentiation in Hbmscs and MC3T3-E1 Cells through the Modulation of Oxidative Stress and PI3K/AKT/Nrf2 Pathway. Connective Tissue Research, 65, 293-303. [Google Scholar] [CrossRef] [PubMed]
[53] Wang, Y. and Yi, Y. (2024) CISD2 Downregulation Participates in the Ferroptosis Process of Human Ovarian SKOV-3 Cells through Modulating the Wild Type P53-Mediated GLS2/SAT1/SLC7A11 and Gpx4/TRF Signaling Pathway. Tissue and Cell, 89, Article ID: 102458. [Google Scholar] [CrossRef] [PubMed]
[54] Li, Y., Xu, B., Ren, X., Wang, L., Xu, Y., Zhao, Y., et al. (2022) Inhibition of CISD2 Promotes Ferroptosis through Ferritinophagy-Mediated Ferritin Turnover and Regulation of p62-Keap1-NRF2 Pathway. Cellular & Molecular Biology Letters, 27, Article No. 81. [Google Scholar] [CrossRef] [PubMed]
[55] Qiu, C., Li, Z. and Peng, P. (2024) Human Umbilical Cord Mesenchymal Stem Cells Protect MC3T3-E1 Osteoblasts from Dexamethasone-Induced Apoptosis via Induction of the NRF2-Are Signaling Pathway. Regenerative Therapy, 27, 1-11. [Google Scholar] [CrossRef] [PubMed]
[56] Li, Z., Chen, C., Zhu, X., Li, Y., Yu, R. and Xu, W. (2018) Glycyrrhizin Suppresses Rankl-Induced Osteoclastogenesis and Oxidative Stress through Inhibiting NF-κB and MAPK and Activating AMPK/Nrf2. Calcified Tissue International, 103, 324-337. [Google Scholar] [CrossRef] [PubMed]
[57] Choi, Y.J., Oh, H.R., Choi, M.R., Gwak, M., An, C.H., Chung, Y.J., et al. (2014) Frameshift Mutation of a Histone Methylation-Related Gene SETD1B and Its Regional Heterogeneity in Gastric and Colorectal Cancers with High Microsatellite Instability. Human Pathology, 45, 1674-1681. [Google Scholar] [CrossRef] [PubMed]
[58] Förster, B., Demangel, C. and Thye, T. (2020) Mycolactone Induces Cell Death by SETD1B-Dependent Degradation of Glutathione. PLOS Neglected Tropical Diseases, 14, e0008709. [Google Scholar] [CrossRef] [PubMed]
[59] Gawargi, F.I. and Mishra, P.K. (2024) Regulation of Cardiac Ferroptosis in Diabetic Human Heart Failure: Uncovering Molecular Pathways and Key Targets. Cell Death Discovery, 10, Article No. 268. [Google Scholar] [CrossRef] [PubMed]
[60] Yin, Z., Zhang, J., Zhao, M., et al. (2024) EDIL3/Del-1 Prevents Aortic Dissection through Enhancing Internalization and Degradation of Apoptotic Vascular Smooth Muscle Cells. Autophagy, 20, 2405-2425.
[61] Sevim-Wunderlich, S., Dang, T., Rossius, J., Schnütgen, F. and Kühn, R. (2024) A Mouse Model of X-Linked Chronic Granulomatous Disease for the Development of Crispr/cas9 Gene Therapy. Genes, 15, Article 706. [Google Scholar] [CrossRef] [PubMed]
[62] Ciesielska, A., Matyjek, M. and Kwiatkowska, K. (2020) TLR4 and CD14 Trafficking and Its Influence on LPS-Induced Pro-Inflammatory Signaling. Cellular and Molecular Life Sciences, 78, 1233-1261. [Google Scholar] [CrossRef] [PubMed]
[63] Cui, H., Li, J., Li, X., Su, T., Wen, P., Wang, C., et al. (2024) TNF-α Promotes Osteocyte Necroptosis by Upregulating TLR4 in Postmenopausal Osteoporosis. Bone, 182, Article ID: 117050. [Google Scholar] [CrossRef] [PubMed]
[64] Zhang, Y. and Zhao, Q. (2020) AEG-1 Deletion Promotes Cartilage Repair and Modulates Bone Remodeling-Related Cytokines via TLR4/MyD88/NF-κB Inhibition in Ovariectomized Rats with Osteoporosis. Annals of Translational Medicine, 8, 1298-1298. [Google Scholar] [CrossRef] [PubMed]
[65] Zhao, C., Yu, T., Dou, Q., Guo, Y., Yang, X. and Chen, Y. (2020) Knockout of TLR4 Promotes Fracture Healing by Activating Wnt/β-Catenin Signaling Pathway. Pathology—Research and Practice, 216, Article ID: 152766. [Google Scholar] [CrossRef] [PubMed]
[66] Huang, B., Nie, G., Dai, X., Cui, T., Pu, W. and Zhang, C. (2024) Environmentally Relevant Levels of Cd and Mo Coexposure Induces Ferroptosis and Excess Ferritinophagy through AMPK/mTOR Axis in Duck Myocardium. Environmental Toxicology, 39, 4196-4206. [Google Scholar] [CrossRef] [PubMed]
[67] Zhong, L., Sun, Y., Wang, C., Liu, R., Ru, W., Dai, W., et al. (2024) SP1 Regulates BMSC Osteogenic Differentiation through the miR-133a-3p/MAPK3 Axis: SP1 Regulates Osteogenic Differentiation of BMSCs. Journal of Orthopaedic Surgery and Research, 19, Article No. 396. [Google Scholar] [CrossRef] [PubMed]
[68] Zhang, J., Mo, L., Huang, H., Xu, J., Fan, Y., Li, W., et al. (2022) Loureirin B Downregulates Osteoclast Differentiation of Bone Marrow Macrophages by Targeting the MAPK Signaling Pathway. Scientific Reports, 12, Article No. 14382. [Google Scholar] [CrossRef] [PubMed]
[69] Yang, Y., Zhou, X., Li, Y., Chen, A., Liang, W., Liang, G., et al. (2019) CXCL2 Attenuates Osteoblast Differentiation by Inhibiting the ERK1/2 Signaling Pathway. Journal of Cell Science, 132, jcs230490. [Google Scholar] [CrossRef] [PubMed]
[70] Ma, T., Chen, T., Li, P., Ye, Z., Zhai, W., Jia, L., et al. (2016) Heme Oxygenase-1 (HO-1) Protects Human Lens Epithelial Cells (SRA01/04) against Hydrogen Peroxide (h2o2)-Induced Oxidative Stress and Apoptosis. Experimental Eye Research, 146, 318-329. [Google Scholar] [CrossRef] [PubMed]
[71] Zwerina, J., Tzima, S., Hayer, S., Redlich, K., Hoffmann, O., Hanslik‐Schnabel, B., et al. (2005) Heme Oxygenase 1 (HO‐1) Regulates Osteoclastogenesis and Bone Resorption. The FASEB Journal, 19, 2011-2013. [Google Scholar] [CrossRef] [PubMed]
[72] Barbagallo, I., Vanella, A., Peterson, S.J., Kim, D.H., Tibullo, D., Giallongo, C., et al. (2009) Overexpression of Heme Oxygenase-1 Increases Human Osteoblast Stem Cell Differentiation. Journal of Bone and Mineral Metabolism, 28, 276-288. [Google Scholar] [CrossRef] [PubMed]
[73] Chu, M., Chen, G., Chen, K., Zhu, P., Wang, Z., Qian, Z., et al. (2024) Heme Oxygenase 1 Linked to Inactivation of Subchondral Osteoclasts in Osteoarthritis. Journal of Zhejiang University-SCIENCE B, 25, 513-528. [Google Scholar] [CrossRef] [PubMed]
[74] Tao, L., Wang, J., Wang, K., Liu, Q., Li, H., Xu, S., et al. (2024) Exerkine FNDC5/Irisin-Enriched Exosomes Promote Proliferation and Inhibit Ferroptosis of Osteoblasts through Interaction with Caveolin‐1. Aging Cell, 23, e14181. [Google Scholar] [CrossRef] [PubMed]
[75] Liu, X., Ji, C., Xu, L., Yu, T., Dong, C. and Luo, J. (2018) Hmox1 Promotes Osteogenic Differentiation at the Expense of Reduced Adipogenic Differentiation Induced by BMP9 in C3H10T1/2 Cells. Journal of Cellular Biochemistry, 119, 5503-5516. [Google Scholar] [CrossRef] [PubMed]
[76] Sakauchi, C., Wakatsuki, H., Ichijo, H. and Hattori, K. (2017) Pleiotropic Properties of ASK1. Biochimica et Biophysica Acta (BBA)—General Subjects, 1861, 3030-3038. [Google Scholar] [CrossRef] [PubMed]
[77] Lu, Y., Liu, Y. and Zheng, M. (2022) The Role and Regulation of Apoptosis Signal-Regulated Kinase 1 in Liver Disease. Molecular Biology Reports, 49, 10905-10914. [Google Scholar] [CrossRef] [PubMed]
[78] Han, Y., Feng, H., Sun, J., Liang, X., Wang, Z., Xing, W., et al. (2019) Lkb1 Deletion in Periosteal Mesenchymal Progenitors Induces Osteogenic Tumors through Mtorc1 Activation. Journal of Clinical Investigation, 129, 1895-1909. [Google Scholar] [CrossRef] [PubMed]
[79] Lai, L.P., Lotinun, S., Bouxsein, M.L., Baron, R. and McMahon, A.P. (2014) Stk11 (Lkb1) Deletion in the Osteoblast Lineage Leads to High Bone Turnover, Increased Trabecular Bone Density and Cortical Porosity. Bone, 69, 98-108. [Google Scholar] [CrossRef] [PubMed]
[80] Xie, J., Zhang, H., Wang, K., Ni, J., Ma, X., Khoury, C.J., et al. (2023) M6A-Mediated-Upregulation of lncRNA BLACAT3 Promotes Bladder Cancer Angiogenesis and Hematogenous Metastasis through YBX3 Nuclear Shuttling and Enhancing NCF2 Transcription. Oncogene, 42, 2956-2970. [Google Scholar] [CrossRef] [PubMed]
[81] Sánchez-de-Diego, C., Pedrazza, L., Pimenta-Lopes, C., Martinez-Martinez, A., Dahdah, N., Valer, J.A., et al. (2021) NRF2 Function in Osteocytes Is Required for Bone Homeostasis and Drives Osteocytic Gene Expression. Redox Biology, 40, Article ID: 101845. [Google Scholar] [CrossRef] [PubMed]
[82] Ma, Y., Feng, J., Xing, X., Zhou, B., Li, S., Zhang, W., et al. (2016) miR-1908 Overexpression Inhibits Proliferation, Changing Akt Activity and P53 Expression in Hypoxic NSCLC Cells. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics, 24, 9-15. [Google Scholar] [CrossRef] [PubMed]
[83] Wiza, C., Nascimento, E.B.M. and Ouwens, D.M. (2012) Role of PRAS40 in Akt and mTOR Signaling in Health and Disease. American Journal of Physiology-Endocrinology and Metabolism, 302, E1453-E1460. [Google Scholar] [CrossRef] [PubMed]
[84] Malla, R., Ashby, C.R., Narayanan, N.K., Narayanan, B., Faridi, J.S. and Tiwari, A.K. (2015) Proline-Rich AKT Substrate of 40-kDa (PRAS40) in the Pathophysiology of Cancer. Biochemical and Biophysical Research Communications, 463, 161-166. [Google Scholar] [CrossRef] [PubMed]
[85] He, X., Wang, D., Yi, Y., Tan, Y., Wu, M., Wang, H., et al. (2023) δ-Tocotrienol Preconditioning Improves the Capability of Bone Marrow-Derived Mesenchymal Stem Cells in Promoting Wound Healing by Inhibiting BACH1-Related Ferroptosis. Cell Death Discovery, 9, Article No. 349. [Google Scholar] [CrossRef] [PubMed]
[86] Wada, S., Kanzaki, H., Katsumata, Y., Yamaguchi, Y., Narimiya, T., Attucks, O.C., et al. (2020) Bach1 Inhibition Suppresses Osteoclastogenesis via Reduction of the Signaling via Reactive Oxygen Species by Reinforced Antioxidation. Frontiers in Cell and Developmental Biology, 8, Article 740. [Google Scholar] [CrossRef] [PubMed]
[87] Yuan, Z., Li, J., Zou, X., Liu, C., Lu, J., Ni, C., et al. (2023) Knockdown of Bach1 Protects Periodontal Bone Regeneration from Inflammatory Damage. Journal of Cellular and Molecular Medicine, 27, 3465-3477. [Google Scholar] [CrossRef] [PubMed]
[88] Zhang, J., Ye, Z., Morgenstern, R., Townsend, D.M. and Tew, K.D. (2023) Microsomal Glutathione Transferase 1 in Cancer and the Regulation of Ferroptosis. Advances in Cancer Research, 160, 107-132. [Google Scholar] [CrossRef] [PubMed]
[89] Li, Y., Xu, X., Wang, X., Zhang, C., Hu, A. and Li, Y. (2023) MGST1 Expression Is Associated with Poor Prognosis, Enhancing the Wnt/β-Catenin Pathway via Regulating AKT and Inhibiting Ferroptosis in Gastric Cancer. ACS Omega, 8, 23683-23694. [Google Scholar] [CrossRef] [PubMed]
[90] Jain, P., Karthikeyan, C., Moorthy, N.S., Waiker, D., Jain, A. and Trivedi, P. (2014) Human Cdc2-Like Kinase 1 (CLK1): A Novel Target for Alzheimer’s Disease. Current Drug Targets, 15, 539-550. [Google Scholar] [CrossRef] [PubMed]
[91] Mullin, S. and Schapira, A. (2013) Α-Synuclein and Mitochondrial Dysfunction in Parkinson’s Disease. Molecular Neurobiology, 47, 587-597. [Google Scholar] [CrossRef] [PubMed]
[92] Calabrese, G., Mesner, L.D., Foley, P.L., Rosen, C.J. and Farber, C.R. (2016) Network Analysis Implicates α-Synuclein (Snca) in the Regulation of Ovariectomy-Induced Bone Loss. Scientific Reports, 6, Article No. 29475. [Google Scholar] [CrossRef] [PubMed]
[93] Yu, L., Sui, B., Zhang, X., Liu, J., Hao, X. and Zheng, L. (2023) miR-92a-1-5p Enriched Prostate Cancer Extracellular Vesicles Regulate Osteoclast Function via MAPK1 and FoxO1. Journal of Experimental & Clinical Cancer Research, 42, Article No. 109. [Google Scholar] [CrossRef] [PubMed]
[94] Li, Q., Wu, M., Fang, G., Li, K., Cui, W., Li, L., et al. (2021) MicroRNA-186-5p Downregulation Inhibits Osteoarthritis Development by Targeting MAPK1. Molecular Medicine Reports, 23, Article No. 253. [Google Scholar] [CrossRef] [PubMed]
[95] Lu, X., Xu, Y., Li, X., Wang, J., Wang, L., Hu, X., et al. (2024) Selective STAT3 Inhibitor STX-0119 Alleviates Osteoarthritis Progression by Modulating the STAT3/PPARγ Signaling Pathway. Biochemical Pharmacology, 227, Article ID: 116420. [Google Scholar] [CrossRef] [PubMed]
[96] He, E., Sui, H., Wang, H., Zhao, X., Guo, W., Dai, Z., et al. (2024) Interleukin-19 in Bone Marrow Contributes to Bone Loss via Suppressing Osteogenic Differentiation Potential of BMSCs in Old Mice. Stem Cell Reviews and Reports, 20, 1311-1324. [Google Scholar] [CrossRef] [PubMed]
[97] Liu, H., Liu, H., Yang, Q. and Fan, Z. (2024) LncRNA SNHG1 Enhances Cartilage Regeneration by Modulating Chondrogenic Differentiation and Angiogenesis Potentials of JBMMSCs via Mitochondrial Function Regulation. Stem Cell Research & Therapy, 15, Article No. 177. [Google Scholar] [CrossRef] [PubMed]
[98] Chen, H., Ji, X., Lee, W., Shi, Y., Li, B., Abel, D., et al. (2019) Increased Glycolysis Mediates Wnt7b‐Induced Bone Formation. The FASEB Journal, 33, 7810-7821. [Google Scholar] [CrossRef] [PubMed]
[99] Qi, B., Li, C., Cai, X., Pu, L., Guo, M., Tang, Z., et al. (2023) Bioinformatics-Based Analysis of Key Genes in Steroid-Induced Osteonecrosis of the Femoral Head That Are Associated with Copper Metabolism. Biomedicines, 11, Article 873. [Google Scholar] [CrossRef] [PubMed]
[100] Wu, Z., Wen, Y., Fan, G., He, H., Zhou, S. and Chen, L. (2021) HEMGN and SLC2A1 Might Be Potential Diagnostic Biomarkers of Steroid-Induced Osteonecrosis of Femoral Head: Study Based on WGCNA and DEGs Screening. BMC Musculoskeletal Disorders, 22, Article No. 85. [Google Scholar] [CrossRef] [PubMed]

为你推荐